Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Texas A&M University
Information provided by (Responsible Party):
Marielle PKJ Engelen, PhD, Texas A&M University Identifier:
First received: June 5, 2012
Last updated: October 17, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2019
  Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)